This evidence suggests that Tfh may mature at site of inflammation, and IL-6 exhibits crucial roles for Tfh cell generation during humoral response, which would allow focusing on IL-6 as a target to downregulate Tfh cells frequency, since IL-6 is increased in SS [29]. This evidence concerns the gene IL6 and synovial sarcoma.